아시아 태평양 완하제 시장 – 2030년까지의 산업 동향 및 예측

아시아 태평양 완하제 시장 분석 및 규모

아시아 태평양 완하제 시장은 고령화 인구 증가의 높은 부담으로 인해 상당한 성장을 경험했으며, 이는 시장 수요를 촉진한 주요 원동력입니다. 완하제 제품과 관련된 높은 수준의 안전성과 천연, 합성 및 생분해성 소재로 완하제를 생산하는 데 대한 강조가 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다.                          

Data Bridge Market Research는 2022년에 6,914.12백만 달러였던 아시아 태평양 완하제 시장이 2030년까지 12,034.12백만 달러에 도달할 것으로 예상하고, 2023년에서 2030년까지의 예측 기간 동안 7.0%의 CAGR을 보일 것으로 분석했습니다. "삼투성 완하제"는 라이프스타일과 식단의 변화로 인해 아시아 태평양 완하제 시장의 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

아시아 태평양 완하제 시장 범위 및 세분화

시장 정의

완하제는 배변을 증가/자극하거나 대변을 풀어주는 작용제입니다. 장내 이동을 가속화하여 소화관의 움직임을 가속화하여 배변을 자극하는 데 도움이 됩니다. 변비는 어렵고 드물며 때로는 고통스러운 배변을 특징으로 하는 질환입니다. 완하제는 일반의약품(OTC)으로 판매됩니다. 네 가지 주요 완하제는 삼투성 완하제, 자극성 완하제, 대량 완하제, 윤활제 및 완화성 완하제입니다.

아시아 태평양 완하제 시장 동향

운전자

• 라이프스타일과 식습관의 변화

아시아 태평양 지역은 지난 수십 년 동안 라이프스타일과 식습관에 상당한 변화를 겪었습니다. 도시화가 가속화되고 앉아서만 있는 라이프스타일이 더 널리 퍼지면서 특히 변비와 같은 위장 문제가 눈에 띄게 증가했습니다. 이러한 변화는 신체 활동 감소, 섬유질 섭취 부족, 가공 식품과 편의 식품에 대한 선호도 증가에 기인할 수 있습니다. 이러한 식단 및 라이프스타일 변화로 인해 변비 발생률이 증가하여 이 지역에서 완하제 제품에 대한 수요가 증가했습니다.

• 건강 관리 인식 증가

아시아 태평양 지역에서는 의료에 대한 인식과 접근성이 눈에 띄게 증가했습니다. 이러한 인식 증가로 인해 변비를 포함한 위장 장애에 대한 인식과 진단이 더욱 확대되었습니다. 이제 환자들은 의학적 조언을 구하고 제약 솔루션을 선택할 가능성이 더 높아져 완하제 시장이 확대되는 데 기여하고 있습니다.

• OTC 완하제에 대한 소비자 선호도

처방전 없이 구입할 수 있는(OTC) 완하제는 편리함과 접근성으로 인해 아시아 태평양 지역에서 인기를 얻고 있습니다. 소비자들은 처방전 없이도 이러한 제품을 쉽게 구매할 수 있다는 점을 높이 평가합니다. 게다가, OTC 완하제는 종종 경미하고 가끔씩 나타나는 변비에 대한 1차 치료제로 간주됩니다. 쉽게 구할 수 있는 OTC 완하제에 대한 소비자들의 이러한 선호도는 완하제 시장의 성장을 더욱 촉진했습니다.

기회

• 건강과 웰빙 트렌드 상승

소비자들 사이에서 건강과 웰빙에 대한 관심이 높아지면서 완하제 제조업체들에게 주목할 만한 기회가 생겼습니다. 단순히 변비를 완화하는 것 외에도 제조업체는 자사 제품을 전반적인 소화 건강에 기여하는 제품으로 포지셔닝할 수 있습니다. 이러한 접근 방식은 전체적인 웰빙을 증진하는 제품을 찾는 소비자들의 증가하는 추세와 일치하여 시장 성장을 위한 잠재적인 길을 만듭니다.

• 완하제 제형의 제품 혁신

완하제 제형의 지속적인 혁신은 시장 확장에 상당한 기회를 제공합니다. 제조업체는 연구 개발에 투자하여 부작용이 적은 더 부드럽고 자연스러운 완하제를 개발할 수 있습니다. 완하제 사용과 관련된 내성을 높이고 불편함을 줄이는 혁신은 변비 완화를 위한 효과적이면서도 부드러운 솔루션을 찾는 소비자에게 공감을 얻을 수 있습니다.

제약/도전

• 엄격한 규제 감독

아시아 태평양 지역의 규제 기관은 완하제를 포함한 의약품의 판매 및 유통에 대한 엄격한 규정을 부과합니다. 이러한 규정은 소비자 안전과 제품 효능을 보장하기 위해 마련되었습니다. 제조업체는 엄격한 표준을 준수하고 엄격한 테스트 및 승인 절차를 거쳐야 합니다. 규제 요건을 준수하면 운영 비용이 증가하고 마케팅 활동에 제한이 생겨 시장에 상당한 제약이 발생할 수 있습니다.

• 아시아 태평양 지역의 문화 및 식단 변화

아시아 태평양 지역의 문화적, 식단적 차이는 완하제 마케팅에 대한 미묘하고 문화적으로 민감한 접근 방식을 요구합니다. 제조업체는 제품을 홍보할 때 지역적 선호도, 전통적 치료법 및 의료 관행을 고려해야 합니다. 이러한 문화적 요소를 효과적으로 탐색하지 못하면 시장 수용 및 성공에 영향을 미칠 수 있습니다.

This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range

Asia-Pacific Laxative Market Analysis and Size

Asia-Pacific laxative market has experienced significant growth due to the high burden of an increase in aging population are the major drivers which propelled the demand of the market. High level safety associated with laxative products and rising emphasis on production of laxatives from natural, synthetic and biodegradable materials are the major drivers which propelled the demand of the market in the forecast period.             

Data Bridge Market Research analyses that the Asia-Pacific laxative market which was USD 6,914.12 million in 2022, is expected to reach USD 12,034.12 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030. “Osmotic Laxatives” dominates the type segment of the Asia-Pacific laxative market due to changing lifestyle and dietary. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Laxative Market Scope and Segmentation

Market Definition

Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.

Asia-Pacific Laxative Market Dynamics

Drivers

• Changing Lifestyle and Dietary Habits

The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.

• Increased Healthcare Awareness

The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.

• Consumer Preference for OTC Laxatives

Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.

Opportunities

• Rising Health and Wellness Trends

The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.

• Product Innovation in Laxative Formulation

Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.

Restraints/Challenges

• Stringent Regulatory Oversight

Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.

• Cultural and Dietary Variations across the Asia-Pacific

Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.

This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range

Asia-Pacific Laxative Market Scope

The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Osmotic Laxatives
• Stimulant Laxatives
• Bulk Laxatives and Lubricant
• Emollient laxatives

Flavors

• With Flavors
• Without Flavors

Source

• Natural
• Synthetic
• Others

Indication

• Chronic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-Induced constipation
• Acute constipation
• Others

Mode of Purchase

• Prescription
• Over-the-Counter

Dosage Form

• Tablets
• Capsules
• Powder
• Liquid and Gels
• Suppositories
• Others

Route of Administration

• Oral​​​​​​​
• Rectal

Population Type

• Children
• Adults

Sales Channel

• Hospitals
• Elderly Care Centers
• Home Healthcare
• Pharmacy Stores
• Grocery/Health and Beauty Stores
• Others

Distribution Channel

• Direct Sales
• Wholesalers
• Others

Asia-Pacific Laxative Market Regional Analysis/Insights

The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific Laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific Laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific Laxative market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Asia-Pacific Laxative Market Share Analysis

The Asia-Pacific Laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Asia-Pacific laxative market.

Some of the major players operating in the Asia-Pacific laxative market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Ireland)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Lupin (India)
• Fresenius Kabi AG (Germany)
• Aurobindo Pharma (India)
• Cipla Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Amneal Pharmaceuticals LLC. (U.S.)
• Apotex Inc. (Canada)
• Eli Lilly and Company (U.S.)

The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Osmotic Laxatives
• Stimulant Laxatives
• Bulk Laxatives and Lubricant
• Emollient laxatives

Flavors

• With Flavors
• Without Flavors

Source

• Natural
• Synthetic
• Others

Indication

• Chronic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-Induced constipation
• Acute constipation
• Others

Mode of Purchase

• Prescription
• Over-the-Counter

Dosage Form

• Tablets
• Capsules
• Powder
• Liquid and Gels
• Suppositories
• Others

Route of Administration

• Oral
• Rectal

Population Type

• Children
• Adults

Sales Channel

• Hospitals
• Elderly Care Centers
• Home Healthcare
• Pharmacy Stores
• Grocery/Health and Beauty Stores
• Others

Distribution Channel

• Direct Sales
• Wholesalers
• Others

Asia-Pacific Laxative Market Regional Analysis/Insights

The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

아시아 태평양 완하제 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 아시아 태평양 완하제 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 아시아 태평양 완하제 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2015년부터 2020년까지의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 아시아 태평양 완하제 시장 점유율 분석

아시아 태평양 완하제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 아시아 태평양 완하제 시장과 관련된 회사의 초점에만 관련이 있습니다.

아시아 태평양 완하제 시장에서 활동하는 주요 기업은 다음과 같습니다.

• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd. (아일랜드)
• 사노피(프랑스)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 노바티스 AG(스위스)
• 머크앤코(미국)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 히크마 제약(영국)
• Dr. Reddy's Laboratories Ltd. (인도)
• 루팡(인도)
• Fresenius Kabi AG(독일)
• Aurobindo Pharma(인도)
• 시플라 주식회사(미국)
• Bausch Health Companies Inc. (캐나다)
• Amneal Pharmaceuticals LLC. (미국)
• Apotex Inc. (캐나다)
• 엘리 릴리 앤드 컴퍼니(미국)

SKU-63762